Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
COMPASS Pathways Reports $253.8 Million Net Loss in Q2 2026 Amid Clinical Advancements
COMPASS Pathways Reports $91.2M Net Income in Latest Quarterly Results
COMPASS Pathways Reports $287.9 Million Net Loss and Business Update in 10-K Filing
COMPASS Pathways Reports $137.7 Million Net Loss in Q3 2025, Progresses in Clinical Trials
COMPASS Pathways Reports Q2 2025 Financial Results with Increased Losses and Advancements in Clinical Trials
COMPASS Pathways Reports Q1 2025 Financial Results with Improved Net Loss
COMPASS Pathways Reports Significant Losses, Restructuring Amid Ongoing Clinical Trials and Funding Efforts